Data as of Jul 30
| +0.42 / +1.24%|
The 2 analysts offering 12-month price forecasts for Cantel Medical Corp have a median target of 40.00, with a high estimate of 43.00 and a low estimate of 37.00. The median estimate represents a +16.21% increase from the last price of 34.42.
The current consensus among 2 polled investment analysts is to Buy stock in Cantel Medical Corp. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.